Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ketamine for Vaso-Occlusive Pain in Adolescents and Young Adults
NCT05378555Phase 1Completed
- Sponsor
- Boston Children's Hospital
- Start
- May 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in vaso-occlusive crisis (VOC), sponsored by Boston Children's Hospital. Primary endpoint: Visual Analogue Scale Pain Score at 48 hours. Started May 2023; status: completed.
02
Drugs
ketamine
03
Conditions
vaso-occlusive crisis (VOC)
Beyond the preview
Go deeper on NCT05378555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378555.